Listed

DeFi Capital Markets, Inc.: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 19, 2019 and accepted by EDGAR at Aug 19, 2019, 15:48 ET.

Share

Management's discussion and analysis

As filed, 17,073 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission.

overview

We are in the business of marketing and distributing safety and security products which are primarily manufactured through our 50%-owned Hong Kong Joint Venture. Our financial statements detail our sales and other operational results only, and report the financial results of the Hong Kong Joint Venture using the equity method. Accordingly, the following discussion and analysis of the three month periods ended June 30, 2019 and 2018 relate to the operational results of the Company. A discussion and analysis of the Hong Kong Joint Venture’s operational results for these periods is presented below under the heading “Joint Venture.”

The Company has developed products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. To date we have applied for thirteen patents on these new technologies and features. We have been granted ten patents (including six for new technologies and features). Most of our new technologies and features have been trademarked under the trade name IoPhic.

Changes in international trade duties and other aspects of international trade policy, both in the U.S. and abroad, could materially impact the cost of our products. All of our products are imported from the Peoples Republic of China (PRC). To date, our ground fault circuit interrupters (GFCI), which constitute only a small portion of our sales, have been included in products subject to a 25% tariff effective August 23, 2018. Additionally, tariffs of 25% have been imposed on our Carbon Monoxide and Photoelectric alarms and additional tariffs of 10% have been proposed on the remainder of items the Company imports beginning after September 1, 2019. We are monitoring these developments and will determine our strategies as additional information becomes available. Any increase in tariffs that is not offset by an increase in our sales prices could have an adverse effect on our business, financial position, results of operations or cash flows.

Results of Operations

Three Months Ended June 30, 2019 and 2018

Sales. Net sales for the three months ended June 30, 2019 were $4,343,291 compared to $4,045,996 for the comparable three months in the prior year, an increase of $297,295 (7.3%). Sales increased principally due to the increased sales of ground fault circuit interrupters and other electrical devices and accessories.

Gross Profit Margin. Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 28.7% and 30.7% of sales for the quarters ended June 30, 2019 and 2018, respectively. The decrease in gross profit margin was primarily due to the increase in tariffs as discussed above.

Expenses. Selling, general and administrative expenses were $1,236,839 for the three months ended June 30, 2019, compared to $1,197,771 for the comparable three months in the prior year. As a percentage of net sales, these expenses decreased to 28.5% for the three month period ended June 30, 2019, from 29.6% for the 2018 period. These expenses decreased as a percentage of net sales since selling, general, and administrative expenses do not increase in direct proportion to increased sales.

Research and development expenses were $140,643 for the three month period ended June 30, 2019 compared to $153,387 for the comparable quarter of the prior year, a decrease of $12,744 (8.3%). The primary reasons for the decrease are decreased expenditures paid to independent testing facilities as the sealed product line has been completed.

Interest Expense and Other. Our interest expense was $107,337 for the quarter ended June 30, 2019, compared to interest expense of $83,419 for the quarter ended June 30, 2018. Interest expense is dependent upon the total amounts borrowed on average from the Factor and on extended trade payables due to the Hong Kong Joint Venture. Amounts due to the Hong Kong Joint Venture increased in the current fiscal year’s three month period as compared to the same period in the prior fiscal year.

Net Loss. We reported a net loss of $608,954 for the quarter ended June 30, 2019, compared to a net loss of $438,833 for the corresponding quarter of the prior fiscal year, a $170,121 (38.8%) increase in the net loss. The net loss increased principally due to the increase in the Company’s equity in the loss of the Hong Kong Joint Venture.

Joint Venture

Net Sales. Net sales of the Joint Venture for the three months ended June 30, 2019 were $3,149,100, compared to $3,266,557, for the comparable period in the prior fiscal year. The net sales of the Joint Venture were generally comparable with the three month period of the prior fiscal year. While sales to the Company increased during this period when compared to the prior year, the Joint Venture’s net sales to other unaffiliated customers decreased from the prior year’s period.

Gross Profit Margin. Gross margins of the Joint Venture for the three month period ended June 30, 2019 decreased to 5.1% from 10.6% for the 2018 corresponding period. Gross margins depend on sales volume of various products, with varying margins, accordingly, increased sales of higher margin products and decreased sales of lower margin products positively affect the overall gross margins.

Expenses. Selling, general and administrative expenses were $1,077,299 for the three month periods ended June 30, 2019, compared to $1,137,851 in the comparable period in the prior year. As a percentage of sales, expenses were 34.2% for the three month period ended June 30, 2019, compared to 34.8% for the three month period ended June 30, 2018.

Interest Income. Interest income on assets held for investment was $64,384 for the three month period ended June 30, 2019, compared to interest income of $40,046 for the prior year’s period. Interest income is dependent on the average balance of assets held for investment.

Net Loss. Net loss for the three months ended June 30, 2019 was $808,833 compared to a net loss of $546,959 in the comparable period last year. The increase in the net loss for the three month period is due primarily to decreased gross profit margins.

Liquidity. Cash needs of the Joint Venture are currently met by funds generated from operations and existing cash and marketable securities. During the three months ended June 30, 2019, working capital decreased by $1,586,215 from $11,608,698 on March 31, 2019 to $10,022,483 on June 30, 2019.

Management Plans and Liquidity

The Company had net losses of $608,954 for the three months ended June 30, 2019 and $1,347,986 and $2,262,310 for the years ended March 31, 2019 and 2018, respectively. Furthermore, as of June 30, 2019, working capital (computed as the excess of current assets over current liabilities) decreased by $400,973 from $2,354,313 at March 31, 2019, to $1,953,340 at June 30, 2019.

Our short-term borrowings to finance operating losses, trade accounts receivable, and foreign inventory purchases are provided pursuant to the terms of our Factoring Agreement with Merchant Factors Corporation (Merchant or Factor). Borrowings under our Factoring Agreement bear interest at prime plus 2% and are secured by trade accounts receivable and inventory. Advances from Merchant are at the sole discretion of Merchant based on their assessment of the Company’s receivables, inventory and financial condition at the time of each request for an advance. The unused availability of this facility totaled approximately $268,500 at June 30, 2019. In addition, we have secured extended payment terms for purchases up to $4,000,000 from our Hong Kong Joint Venture for the purchase of sealed battery alarms. These amounts are unsecured, bear interest at 5.5% per annum, and provide for repayment terms of 120 days for each purchase. The balance outstanding under this agreement at June 30, 2019 was $5,625,164 with $2,301,890 of this amount being beyond agreed repayment terms. The Hong Kong Joint Venture has provided discretionary approval to allow the Company to exceed the agreed upon repayment terms and has indicated it has no plans or intentions that would materially impact the financial position, operations, or cash flows of the Company.

The Company has a history of sales that are insufficient to generate profitable operations, and has limited sources of financing. Management’s plan in response to these conditions includes increasing sales resulting from the delivery of the Company’s line of sealed battery ionization smoke alarms, carbon monoxide products, and ground fault circuit interrupters. In addition the Company is seeking improved terms on its credit facility with the Hong Kong Joint Venture. The Company has seen positive results on this plan during the fiscal years ended March 31, 2019 and 2018 and through June 30, 2019 due to sales of its product offerings and management expects this growth to continue going forward. Though no assurances can be given, if management’s plan continues to be successful over the next twelve months, the Company anticipates that it should be able to meet its cash needs. Cash flows and credit availability is expected to be adequate to fund operations for one year from the issuance date of this report.

Operating activities provided cash of $5,336 for the three months ended June 30, 2019. This was primarily due to an increase in accounts payable and accrued expenses of $342,457 and a decrease in accounts receivable and amounts due to factor of $521,414 offset by a net loss of $608,954 and an increase in inventories, prepaid expenses and other of $620,468. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $368,964. Operating activities provided cash of $355,666 for the three months ended June 30, 2018. This was primarily due to an increase in accounts payable and accrued expenses of $527,640 and a decrease in accounts receivable and amounts due to factor of $333,004 offset by a net loss of $438,833 and an increase in inventories, prepaid expenses and other of $317,637. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $244,400.

Investing activities did not use or provide cash during the period ended June 30, 2019 or 2018.

Financing activities used cash of $156,210 and $406,755 during the three months ended June 30, 2019 and 2018, respectively, which is comprised of repayments net of advances on the line of credit from our factor.

Critical Accounting Policies and Estimates

In the notes to the consolidated financial statements, and in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K, we have disclosed those accounting policies that we consider to be significant in determining our results of Operations and financial condition. Except as disclosed below, there have been no material changes to those policies that we consider to be significant since the filing of our Form 10-K. The accounting principles used in preparing our unaudited condensed consolidated financial statements conform in all material respects to accounting principles generally accepted in the U.S.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either financing or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. The Company adopted the standard on April 1, 2019, the date it became effective for public companies based on the Company’s fiscal year, using the modified retrospective approach whereby the cumulative effect of adoption was recognized on the adoption date and prior periods were not restated. There was no net cumulative effect adjustment to retained earnings as of April 1, 2019 as a result of this adoption. Upon adoption, the Company elected the package of practical expedients permitted within the standard, which among other things, allows for the carryforward of historical lease classification. The Company also elected the practical expedient provided in a subsequent amendment to the standard that removed the requirement to separate lease and non-lease components, provided certain conditions were met.

The impact of the adoption of this guidance on the Company’s condensed consolidated financial statements is discussed below:

The Company is a lessee in lease agreements for office space. Certain of the Company’s leases contain provisions that provide for one or more options to renew at the Company’s sole discretion. The Company’s leases are comprised of fixed lease payments, with its real estate leases including lease payments subject to a rate or index which may be variable. Certain real estate leases also include executory costs such as common area maintenance (non-lease component). As a practical expedient permitted under ASC 842, the Company has elected to account for the lease and non-lease components as a single lease component. Lease payments, which may include lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable lease amounts based on a rate or index (fixed in substance) as stipulated in the lease contract.

None of the Company’s lease agreements contain any material residual value guarantees or material restrictive covenants. As a result of the Company’s election of the package of practical expedients permitted within ASC 842, which among other things, allows for the carryforward of historical lease classification, all of the Company’s lease agreements in existence at the date of adoption that were classified as operating leases under ASC 840 have been classified as operating leases under ASC 842. Lease expense for payments related to the Company’s operating leases is recognized on a straight-line basis over the related lease term, which includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

Right-of-use assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments as specified in the lease. Right-of-use assets and lease liabilities related to the Company’s operating leases are recognized at the lease commencement date based on the present value of the remaining lease payments over the lease term and amount to $475,538 at the date of adoption. When the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available surrounding the Company’s borrowing rates at the lease commencement date in determining the present value of lease payments. The right-of use asset also includes any lease payments made at or before lease commencement less any lease incentives.

Controls and procedures

As filed, 2,227 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this quarterly report, and have concluded that disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting as discussed below.

Material weaknesses arose in our oversight of the accounting function as well as the disclosure controls and procedures of the Hong Kong Joint Venture (HKJV). The HKJV is a material component of the Company’s consolidated financial statements. With respect to our internal control over financial reporting, these matters above are being discussed among management, the HKJV and our Audit Committee. Management intends to review, revise and improve our internal controls over financial reporting until the material weaknesses in internal control over financial reporting are eliminated. Management’s specific remediation to address these material weaknesses will include among other items: a) enhancing corporate financial reporting resources, particularly for oversight, and process improvement, and b) reinforcing internal policies with all process owners.

Changes in Internal Control over Financial Reporting. There have not been any changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$4.3mus-gaap:Revenues
Gross profit3 months2019-04-01 to 2019-06-30$1.2mus-gaap:GrossProfit
Research and development3 months2019-04-01 to 2019-06-30$140.6kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-04-01 to 2019-06-30$1.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-04-01 to 2019-06-30−$132.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$107.3kus-gaap:InterestExpense
Net income3 months2019-04-01 to 2019-06-30−$609.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30−$0.26us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2019-04-01 to 2019-06-30$5.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-06-30$223.6kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$10.3mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$18.8mus-gaap:Assets
Current liabilitiesAt period end2019-06-30$8.4mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2019-06-30$10.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-19-040627. Last ingested by Listed: Nov 4, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.